Genetics and pharmacogenetics of estrogen response

References

• Kuiper GG, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology138(3), 863–870 (1997).
   PubMed Web of Science ®Google Scholar
• Murdoch FE, Gorski J. The role of ligand in estrogen receptor regulation of gene expression. Mol. Cell Endocrinol.78(3), C103–C108 (1991).
   PubMed Web of Science ®Google Scholar
• Jensen EV. Steroid hormone antagonists. Summary and future challenges. Ann. NY Acad. Sci.761, 1–4 (1995).
   Google Scholar
• Tsai MJ, O’Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem.63, 451–486 (1994).
   PubMed Web of Science ®Google Scholar
• Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol. Lett.127(1–3), 217–224 (2002).
   PubMed Web of Science ®Google Scholar
• Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am. J. Obstet. Gynecol.154(6), 1181–1186 (1986).
   PubMed Web of Science ®Google Scholar
• Turner CH, Sato M, Bryant HU. Raloxifene preserves bone strength and bone mass in ovariectomized rats. Endocrinology135(5), 2001–2005 (1994).
   PubMed Web of Science ®Google Scholar
• Fillit H, Weinreb H, Cholst I et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer’s type. Psychoneuroendocrinology11(3), 337–345 (1986).
   PubMed Web of Science ®Google Scholar
• Colditz GA. Epidemiology of breast cancer. Findings from the nurses’ health study. Cancer71(Suppl. 4), 1480–1489 (1993).
   PubMed Web of Science ®Google Scholar
• Jensen EV, Jordan VC. The estrogen receptor: a model for molecular medicine. Clin. Cancer Res.9(6), 1980–1989 (2003).
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl Acad. Sci. USA93(12), 5925–5930 (1996).
   PubMed Web of Science ®Google Scholar
• Li X, Huang J, Yi P, Bambara RA, Hilf R, Muyan M. Single-chain estrogen receptors (ERs) reveal that the ERα/β heterodimer emulates functions of the ERα dimer in genomic estrogen signaling pathways. Mol. Cell. Biol.24(17), 7681–7694 (2004).
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Gustafsson JA. The novel estrogen receptor-β subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett.410(1), 87–90 (1997).
   PubMed Web of Science ®Google Scholar
• Weyant MJ, Carothers AM, Mahmoud NN et al. Reciprocal expression of ERα and ERβ is associated with estrogen-mediated modulation of intestinal tumorigenesis. Cancer Res.61(6), 2547–2551 (2001).
   PubMed Web of Science ®Google Scholar
• Ogawa S, Inoue S, Watanabe T et al. Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res.26(15), 3505–3512 (1998).
   PubMed Web of Science ®Google Scholar
• Onate SA, Tsai SY, Tsai MJ, O’Malley BW. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science270(5240), 1354–1357 (1995).
   PubMed Web of Science ®Google Scholar
• Lavinsky RM, Jepsen K, Heinzel T et al. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc. Natl Acad. Sci. USA95(6), 2920–2925 (1998).
   PubMed Web of Science ®Google Scholar
• Mak HY, Hoare S, Henttu PM, Parker MG. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell. Biol.19(5), 3895–3903 (1999).
   PubMedGoogle Scholar
• Smith CL, Conneely OM, O’Malley BW. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc. Natl Acad. Sci. USA90(13), 6120–6124 (1993).
   PubMedGoogle Scholar
• Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol. Endocrinol.13(2), 307–319 (1999).
   PubMed Web of Science ®Google Scholar
• Liu YZ, Liu YJ, Recker RR, Deng HW. Molecular studies of identification of genes for osteoporosis: the 2002 update. J. Endocrinol.177(2), 147–196 (2003).
   PubMed Web of Science ®Google Scholar
• Deroo BJ, Korach KS Estrogen receptors and human disease. J. Clin. Invest.116(3), 561–570 (2006).
   PubMed Web of Science ®Google Scholar
• Delaunay F, Pettersson K, Tujague M, Gustafsson JA. Functional differences between the amino-terminal domains of estrogen receptors α and β. Mol. Pharmacol.58(3), 584–590 (2000).
   PubMedGoogle Scholar
• Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptors α and β form heterodimers on DNA. J. Biol. Chem.272(32), 19858–19862 (1997).
   PubMed Web of Science ®Google Scholar
• Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S. Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J. Biol. Chem.272(41), 25832–25838 (1997).
   PubMed Web of Science ®Google Scholar
• Pettersson K, Grandien K, Kuiper GG, Gustafsson JA. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol. Endocrinol.11(10), 1486–1496 (1997).
   PubMed Web of Science ®Google Scholar
• Tremblay A, Tremblay GB, Labrie F, Giguere V. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1. Mol. Cell3(4), 513–519 (1999).
   PubMed Web of Science ®Google Scholar
• McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS. Transcription activation by the human estrogen receptor subtype β (ER β) studied with ER β and ER α receptor chimeras. Endocrinology139(11), 4513–4522 (1998).
   PubMedGoogle Scholar
• Paech K, Webb P, Kuiper GG et al. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science277(5331), 1508–1510 (1997).
   PubMed Web of Science ®Google Scholar
• Benecke A, Chambon P, Gronemeyer H. Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep.1(2), 151–157 (2000).
   PubMedGoogle Scholar
• Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl Acad. Sci. USA90(23), 11162–11166 (1993).
   PubMed Web of Science ®Google Scholar
• Korach KS, Emmen JM, Walker VR et al. Update on animal models developed for analyses of estrogen receptor biological activity. J. Steroid Biochem. Mol. Biol.86(3–5), 387–391 (2003).
   Google Scholar
• Simpson ER. Models of aromatase insufficiency. Semin. Reprod. Med.22(1), 25–30 (2004).
   PubMed Web of Science ®Google Scholar
• Weihua Z, Saji S, Makinen S et al. Estrogen receptor (ER) β, a modulator of ERα in the uterus. Proc. Natl Acad. Sci. USA97(11), 5936–5941 (2000).
   PubMed Web of Science ®Google Scholar
• Liu MM, Albanese C, Anderson CM et al. Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J. Biol. Chem.277(27), 24353–24360 (2002).
   PubMed Web of Science ®Google Scholar
• Lindberg MK, Moverare S, Skrtic S et al. Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a “ying yang” relationship between ERα and ERβ in mice. Mol. Endocrinol.17(2), 203–208 (2003).
   PubMedGoogle Scholar
• Matthews J, Wihlen B, Tujague M, Wan J, Strom A, Gustafsson JA. Estrogen receptor (ER) β modulates ERα-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol. Endocrinol.20(3), 534–543 (2006).
   PubMed Web of Science ®Google Scholar
• Hirata S, Shoda T, Kato J, Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol. Metab.14(3), 124–129 (2003).
   PubMed Web of Science ®Google Scholar
• Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science231(4742), 1150–1154 (1986).
   PubMed Web of Science ®Google Scholar
• Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J.7(11), 3385–3388 (1988).
   PubMed Web of Science ®Google Scholar
• Thompson DA, McPherson LA, Carmeci C, deConinck EC, Weigel RJ. Identification of two estrogen receptor transcripts with novel 5´ exons isolated from a MCF7 cDNA library. J. Steroid Biochem. Mol. Biol.62(2–3), 143–153 (1997).
   PubMedGoogle Scholar
• Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V, Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage. Mol. Endocrinol.12(12), 1939–1954 (1998).
   PubMed Web of Science ®Google Scholar
• Kos M, Reid G, Denger S, Gannon F. Minireview: genomic organization of the human ERα gene promoter region. Mol. Endocrinol.15(12), 2057–2063 (2001).
   PubMedGoogle Scholar
• Reid G, Denger S, Kos M, Gannon F. Human estrogen receptor-α: regulation by synthesis, modification and degradation. Cell. Mol. Life Sci.59(5), 821–831 (2002).
   PubMed Web of Science ®Google Scholar
• Sand P, Luckhaus C, Schlurmann K, Gotz M, Deckert J. Untangling the human estrogen receptor gene structure. J. Neural Transm.109(5–6), 567–583 (2002).
   PubMedGoogle Scholar
• Brand H, Kos M, Denger S et al. A novel promoter is involved in the expression of estrogen receptor α in human testis and epididymis. Endocrinology143(9), 3397–3404 (2002).
   Google Scholar
• Okuda Y, Hirata S, Watanabe N, Shoda T, Kato J, Hoshi K. Novel splicing events of untranslated first exons in human estrogen receptor α (ER α) gene. Endocr. J.50(1), 97–104 (2003).
   PubMedGoogle Scholar
• Hirata S, Shoda T, Kato J, Hoshi K. Novel isoforms of the mRNA for human female sex steroid hormone receptors. J. Steroid Biochem. Mol. Biol.83(1–5), 25–30 (2002).
   PubMed Web of Science ®Google Scholar
• Flouriot G, Brand H, Denger S et al. Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J.19(17), 4688–4700 (2000).
   PubMed Web of Science ®Google Scholar
• Poola I, Koduri S, Chatra S, Clarke R. Identification of twenty alternatively spliced estrogen receptor a mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J. Steroid Biochem. Mol. Biol.72(5), 249–258 (2000).
   PubMedGoogle Scholar
• Anandappa SY, Sibson R, Platt-Higgins A, Winstanley JH, Rudland PS, Barraclough R. Variant estrogen receptor α mRNAs in human breast cancer specimens. Int. J. Cancer88(2), 209–216 (2000).
   Google Scholar
• Ye Q, Chung LW, Cinar B, Li S, Zhau HE. Identification and characterization of estrogen receptor variants in prostate cancer cell lines. J. Steroid Biochem. Mol. Biol.75(1), 21–31 (2000).
   Google Scholar
• Koduri S, Poola I. Quantitation of alternatively spliced estrogen receptor α mRNAs as separate gene populations. Steroids66(1), 17–23 (2001).
   Google Scholar
• Bollig A, Miksicek RJ. An estrogen receptor-α splicing variant mediates both positive and negative effects on gene transcription. Mol. Endocrinol.14(5), 634–649 (2000).
   PubMed Web of Science ®Google Scholar
• Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF. Expression of an estrogen receptor α variant protein in cell lines and tumors. Mol. Cell. Endocrinol.166(2), 156–169 (2000).
   PubMedGoogle Scholar
• Horvath G, Leser G, Helou K, Henriksson M. Function of the exon 7 deletion variant estrogen receptor α protein in an estradiol-resistant, tamoxifen-sensitive human endometrial adenocarcinoma grown in nude mice. Gynecol. Oncol.84(2), 271–279 (2002).
   PubMed Web of Science ®Google Scholar
• Murphy LC, Wang M, Coutt A, Dotzlaw H. Novel mutations in the estrogen receptor messenger RNA in human breast cancers. J. Clin. Endocrinol. Metab.81(4), 1420–1478 (1996).
   PubMedGoogle Scholar
• Pink JJ, Wu SQ, Wolf DM, Bilimoria MM, Jordan VC. A novel 80 kDa human estrogen receptor containing a duplication of exons 6 and 7. Nucleic Acids Res.24(5), 962–969 (1996).
   Google Scholar
• Flouriot G, Brand H, Seraphin B, Gannon F. Natural trans-spliced mRNAs are generated from the human estrogen receptor-α (hER α) gene. J. Biol. Chem.277(29), 26244–26251 (2002).
   PubMed Web of Science ®Google Scholar
• Tiffoche C, Vaillant C, Schausi D, Thieulant ML. Novel intronic promoter in the rat ER α gene responsible for the transient transcription of a variant receptor. Endocrinology142(9), 4106–4119 (2001).
   Google Scholar
• Lewandowski S, Kalita K, Kaczmarek L. Estrogen receptor β. Potential functional significance of a variety of mRNA isoforms. FEBS Lett.524(1–3), 1–5 (2002).
   PubMedGoogle Scholar
• Hirata S, Shoda T, Kato J, Hoshi K. The multiple untranslated first exons system of the human estrogen receptor β (ER β) gene. J. Steroid Biochem. Mol. Biol.78(1), 33–40 (2001).
   PubMedGoogle Scholar
• Shoda T, Hirata S, Kato J, Hoshi K. Cloning of the novel isoform of the estrogen receptor β cDNA (ERβ isoform M cDNA) from the human testicular cDNA library. J. Steroid Biochem. Mol. Biol.82(2–3), 201–208 (2002).
   Google Scholar
• Poola I, Abraham J, Baldwin K. Identification of ten exon deleted ERβ mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor β mRNA is distinct from that of estrogen receptor α. FEBS Lett.516(1–3), 133–138 (2002).
   PubMed Web of Science ®Google Scholar
• Inoue S, Ogawa S, Horie K et al. An estrogen receptor β isoform that lacks exon 5 has dominant negative activity on both ERα and ERβ. Biochem. Biophys. Res. Commun.279(3), 814–819 (2000).
   PubMed Web of Science ®Google Scholar
• Price RH Jr, Butler CA, Webb PC, Uht RA, Kushner PJ, Handa RJ. A splice variant of estrogen receptor β missing exon 3 displays altered nuclear localization and capacity for transcriptional activation. Endocrinology142, 2039–2049 (2001).
   Google Scholar
• Moore JT, McKee DD, Slentz-Kesler K et al. Cloning and characterization of human estrogen receptor β isoforms. Biochem. Biophys. Res. Commun.247(1), 75–78 (1998).
   PubMed Web of Science ®Google Scholar
• Tong D, Schuster E, Seifert M, Czerwenka K, Leodolte S, Zeillinger R. Expression of estrogen receptor β isoforms in human breast cancer tissues and cell lines. Breast Cancer Res. Treat.71(3), 249–255 (2002).
   Google Scholar
• Omoto Y, Kobayashi S, Inoue S et al. Evaluation of oestrogen receptor β wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur. J. Cancer38(3), 380–386 (2002).
   PubMed Web of Science ®Google Scholar
• Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S. Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7. Oncogene22(32), 5011–5020 (2003).
   PubMed Web of Science ®Google Scholar
• Saunders PT, Millar MR, Macpherson S et al. ERβ1 and the ERβ2 splice variant (ERβcx/β2) are expressed in distinct cell populations in the adult human testis. J. Clin. Endocrinol. Metab.87(6), 2706–2715 (2002).
   PubMed Web of Science ®Google Scholar
• Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson JA, Rochefort H. Increased estrogen receptor βcx expression during mammary carcinogenesis. Clin. Cancer Res.11(9), 3170–3174 (2005).
   PubMed Web of Science ®Google Scholar
• Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ERβ isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J. Pathol.207(1), 53–60 (2005).
   PubMedGoogle Scholar
• Zhao C, Toresson G, Xu L, Koehler KF, Gustafsson JA, Dahlman-Wright K. Mouse estrogen receptor β isoforms exhibit differences in ligand selectivity and coactivator recruitment. Biochemistry44(22), 7936–7944 (2005).
   Google Scholar
• Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology131(3), 1305–1312 (1992).
   PubMed Web of Science ®Google Scholar
• Marino M, Pallottini V, Trentalance A. Estrogens cause rapid activation of IP3–PKC-α signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun.245(1), 254–258 (1998).
   PubMed Web of Science ®Google Scholar
• Warner M, Gustafsson JA. Nongenomic effects of estrogen: why all the uncertainty? Steroids71(2), 91–95 (2006).
   Google Scholar
• Losel RM, Falkenstein E, Feuring M et al. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev.83(3), 965–1016 (2003).
   PubMed Web of Science ®Google Scholar
• Taguchi Y, Koslowski M, Bodenner DL. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl. Recept.2(1), 5 (2004).
   Google Scholar
• Bjornstrom L, Sjoberg M. Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions. Mol. Endocrinol.16(10), 2202–2214 (2002).
   PubMedGoogle Scholar
• Marino M, Acconcia F, Trentalance A. Biphasic estradiol-induced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol. Biol. Cell14(6), 2583–2591 (2003).
   Google Scholar
• Mazumdar A, Kumar R. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells. FEBS Lett.535(1–3), 6–10 (2003).
   PubMed Web of Science ®Google Scholar
• Sukocheva OA, Wang L, Albanese N, Pitson SM, Vadas MA, Xia P. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol. Endocrinol.17(10), 2002–2012 (2003).
   PubMed Web of Science ®Google Scholar
• Mishra S, Reichert A, Cunnick J et al. Protein kinase CKIIα interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cell. Oncogene22(51), 8255–8262 (2003). Erratum in: Oncogene23(37), 6325 (2004).
   PubMed Web of Science ®Google Scholar
• Acconcia F, Totta P, Ogawa S et al. Survival versus apoptotic 17β-estradiol effect: role of ER α and ER β activated non-genomic signaling. J. Cell Physiol.203(1), 193–201 (2005).
   PubMed Web of Science ®Google Scholar
• Chambliss KL, Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev.23(5), 665–686 (2002).
   PubMed Web of Science ®Google Scholar
• Toran-Allerand CD, Guan X, MacLusky NJ et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci.22(19), 8391–8401 (2002).
   PubMed Web of Science ®Google Scholar
• Zhao L, Chen S, Ming Wang J, Brinton RD. 17β-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience132(2), 299–311 (2005).
   PubMed Web of Science ®Google Scholar
• Abraham IM, Todman MG, Korach KS, Herbison AE. Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology145(7), 3055–3061 (2004).
   Google Scholar
• Zhang X, Bruice TC. The proficiency of a thermophilic chorismate mutase enzyme is solely through an entropic advantage in the enzyme reaction. Proc. Natl Acad. Sci. USA102(51), 18356–18360 (2005).
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol.16(1), 70–84 (2002).
   PubMed Web of Science ®Google Scholar
• Gennari L, Becherini L, Falchetti A, Masi L, Massart F, Brandi ML. Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms. J. Steroid Biochem. Mol. Biol.81(1), 1–24 (2002).
   PubMed Web of Science ®Google Scholar
• Zuppan PJ. Hall JM, Ponglikitmongkol M, Spielman R, King MC. Polymorphisms at the estrogen receptor (ESR) locus and linkage relationships on chromosome 6q. Cytogenet. Cell Genet.51, 1116 (1989).
   Google Scholar
• Yaich L, Dupont WD, Cavener DR, Parl FF. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res.52, 77–83 (1992).
   PubMed Web of Science ®Google Scholar
• Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J. Natl Cancer Inst.87(22), 1681–1685 (1995).
   PubMed Web of Science ®Google Scholar
• Cai Q, Shu XO, Jin F et al. Genetic polymorphisms in the estrogen receptor α gene and risk of breast cancer: results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev.12, 853–859 (2003).
   PubMed Web of Science ®Google Scholar
• Onland-Moret NC, van Gils CH, Roest M, Grobbee DE, Peeters PH. The estrogen receptor α gene and breast cancer risk (The Netherlands). Cancer Causes Control16(10), 1195–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Zheng SL, Zheng W, Chang BL et al. Joint effect of estrogen receptor β sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Res.63, 7624–7629 (2003).
   PubMed Web of Science ®Google Scholar
• Maguire P, Margolin S, Skoglund J et al. Estrogen receptor Β (ESR2) polymorphisms in familial and sporadic breast cancer. Breast Cancer Res. Treat.94, 145–152 (2005).
   PubMedGoogle Scholar
• Arai N, Strom A, Rafter JJ, Gustafsson JA. Estrogen receptor β mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem. Biophys. Res. Commun.270, 425–431 (2000).
   PubMed Web of Science ®Google Scholar
• Fiorelli G, Picariello L, Martineti V, Tonelli F, Brandi ML. Functional estrogen receptor β in colon cancer cells. Biochem. Biophys. Res. Commun.261, 521–527 (1999).
   PubMed Web of Science ®Google Scholar
• Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor β in malignant human colon. Cancer Res.60, 245–248 (2000).
   PubMed Web of Science ®Google Scholar
• Martineti V, Picariello L, Tognarini I et al. ERβ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components. Endocr. Relat. Cancer12(2), 455–469 (2005) Erratum in: Endocr. Relat. Cancer12(3), 682 (2005).
   PubMed Web of Science ®Google Scholar
• Harris HA, Albert LM, Leathurby Y et al. Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology144, 4241–4249 (2003). Erratum in: Endocrinology.147(5), 2085 (2006).
   PubMed Web of Science ®Google Scholar
• Jemal A, Tiwari RC, Murray T et al. Cancer statistics, 2004. CA Cancer J. Clin.54, 8–29 (2004).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA288, 321–333 (2002).
   PubMed Web of Science ®Google Scholar
• Slattery ML, Sweeney C, Murtaugh M et al. Associations between ERα, ERβ, and AR genotypes and colon and rectal cancer. Cancer Epidemiol. Biomarkers Prev.14(12), 2936–2942 (2005).
   Google Scholar
• Huber A, Bentz EK, Schneeberger C, Huber JC, Hefler L, Tempfer C. Ten polymorphisms of estrogen-metabolizing genes and a family history of colon cancer – an association study of multiple gene-gene interactions. J. Soc. Gynecol. Investig.12(7), E51–E54 (2005).
   PubMedGoogle Scholar
• Wu HJ, Sekine M, Kashima K et al. Mutational analysis of the estrogen receptor-α gene in familial ovarian cancer. J. Obstet. Gynaecol. Res.31(5), 375–83 (2005).
   Google Scholar
• Thellenberg-Karlsson C, Lindstrom S, Malmer B et al. Estrogen receptor β polymorphism is associated with prostate cancer risk. Clin. Cancer Res.12(6), 1936–1941 (2006).
   PubMed Web of Science ®Google Scholar
• Hernandez J, Balic I, Johnson-Pais TL et al. Association between an estrogen receptor α gene polymorphism and the risk of prostate cancer in black men. J. Urol.175(2), 523–527 (2006).
   Google Scholar
• Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch.444, 213–223 (2004).
   PubMed Web of Science ®Google Scholar
• Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet. Gynecol.85, 304–313 (1995).
   PubMed Web of Science ®Google Scholar
• Georgopoulos NA, Adonakis GL, Fotopoulos A et al. Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer. Gynecol. Endocrinol.22(4), 185–189 (2006).
   PubMed Web of Science ®Google Scholar
• Carbonell Sala S, Masi L, Marini F et al. Genetics and pharmacogenetics of osteoporosis. J. Endocrinol. Invest.28(10 Suppl.), 2–7 (2005).
   PubMedGoogle Scholar
• Ioannidis JPA, Ralston SH, Bennett ST et al. Differential genetic effects of ESR1 gene polymorphisms on osteoporotic outcomes. JAMA292(17), 2105–2114 (2004).
   PubMed Web of Science ®Google Scholar
• Rivadeneira F, van Meurs JB, Kant J et al. Estrogen receptor β (ESR2) polymorphisms in interaction with estrogen receptor α (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J. Bone Miner. Res.21(9), 1443–56 (2006).
   PubMed Web of Science ®Google Scholar
• Shearman AM, Karasik D, Gruenthal KM et al. Estrogen receptor β polymorphisms are associated with bone mass in women and men: the Framingham Study. J. Bone Miner. Res.19(5), 773–781 (2004).
   PubMed Web of Science ®Google Scholar
• Wang X, Dykens JA, Perez E et al. Neuroprotective effects of 17β-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol.70(1), 395–404 (2006).
   PubMed Web of Science ®Google Scholar
• Shearman AM, Cooper JA, Kotwinski PJ et al. Estrogen receptor α gene variation and the risk of stroke. Stroke36(10), 2281–2282 (2005).
   PubMed Web of Science ®Google Scholar
• Westberg L, Hakansson A, Melke J et al. Association between the estrogen receptor β gene and age of onset of Parkinson’s disease. Psychoneuroendocrinology29(8), 993–998 (2004).
   Google Scholar
• Hakansson A, Westberg L, Nilsson S et al. Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor β on the susceptibility to Parkinson’s disease. Am. J. Med. Genet. B Neuropsychiatr. Genet.133(1), 88–92 (2005).
   Google Scholar
• Usui C, Shibata N, Ohnuma T et al. No genetic association between the myeloperoxidase gene -463 polymorphism and estrogen receptor-α gene polymorphisms and Japanese sporadic Alzheimer’s disease. Dement. Geriatr. Cogn. Disord.21(5–6), 296–299 (2006).
   Google Scholar
• Corbo RM, Gambina G, Ruggeri M, Scacchi R. Association of estrogen receptor α (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer’s disease and their effect on apolipoprotein E concentrations. Dement. Geriatr. Cogn. Disord.22(1), 67–72 (2006).
   PubMed Web of Science ®Google Scholar
• Monastero R, Cefalu AB, Camarda C et al. Association of estrogen receptor α gene with Alzheimer’s disease: a case–control study. J. Alzheimers Dis.9(3), 273–278 (2006).
   PubMedGoogle Scholar
• Rokach A, Pollak A, Rosen L et al. Estrogen receptor α gene polymorphisms are associated with the angiographic extent of coronary artery disease. J. Clin. Endocrinol. Metab.90(12), 6556–6560 (2005).
   PubMed Web of Science ®Google Scholar
• Shearman AM, Cupples LA, Demissie S et al. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA290, 2263–2270 (2003).
   PubMed Web of Science ®Google Scholar
• Peter I, Shearman AM, Zucker DR et al. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J. Hypertens.23, 2193–2200 (2005).
   PubMed Web of Science ®Google Scholar
• Ellis JA, Infantino T, Harrap SB. Sex-dependent association of blood pressure with estrogen receptor genes ERα and ERβ. J. Hypertens.22, 1127–1131 (2004).
   PubMed Web of Science ®Google Scholar
• Schuit SC, Oei HH, Witteman JC et al. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA291, 2969–2977 (2004).
   PubMed Web of Science ®Google Scholar
• Peter I, Shearman AM, Vasan RS et al. Association of estrogen receptor β gene polymorphisms with left ventricular mass and wall thickness in women. Am. J. Hypertens.18, 1388–1395 (2005).
   Google Scholar
• Zhu Y, Bian Z, Lu P et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science295, 505–508 (2002).
   PubMed Web of Science ®Google Scholar
• Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H. Association of polymorphisms in the estrogen receptor α gene with body fat distribution. Int. J. Obes. Relat. Metab. Disord.27(9), 1020–1027 (2003).
   PubMed Web of Science ®Google Scholar
• Massart F. Human races and pharmacogenomics of effective bone treatments. Gynecol. Endocrinol.20(1), 36–44 (2005).
   PubMed Web of Science ®Google Scholar
• Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics5(1), 57–65 (2004).
   PubMed Web of Science ®Google Scholar
• Herrington DM, Howard TD, Hawkins GA et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N. Engl. J. Med.346(13), 967–974 (2002).
   PubMed Web of Science ®Google Scholar
• Herrington DM, Howard TD. ER-α variants and the cardiovascular effects of hormone replacement therapy. Pharmacogenomics4(3), 269–277 (2003).
   PubMed Web of Science ®Google Scholar
• Slattery ML, Sweeney C, Herrick J et al. ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res. Treat. (2006) (Epub ahead of print).
   Google Scholar
• Masi L, Ottanelli S, Del Monte F et al. Aromatase and estrogen receptor α gene polymorphisms: response of the bone mineral density in post-menopausal women to HRT. Presented at: XXVI Annual Meeting of the ASBMR. Seattle, USA, October 1–5 SU181 (2004).
   Google Scholar
• Silvestri S, Thomsen AB, Gozzini A, Bagger Y, Christiansen C, Brandi ML. Estrogen receptor α and β polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause13(3), 451–461 (2006).
   PubMed Web of Science ®Google Scholar
• Yim CH, Choi JT, Choi HA et al. Association of estrogen receptor α gene microsatellite polymorphism with annual changes in bone mineral density in Korean women with hormone replacement therapy. J. Bone Miner. Metab.23(5), 395–400 (2005).
   PubMedGoogle Scholar
• Yoneda K, Tanji Y, Ikeda N et al. Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan. Cancer Lett.186(2), 223–230 (2002).
   PubMedGoogle Scholar